ROCKWELL MEDICAL INC (RMTI:NASDAQ)
$0.6757 -0.0334 (-4.7102%)
Analysed ROCKWELL MEDICAL INC (RMTI:NASDAQ) News Sources
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
27-03-2026
yahoo.com
Should Value Investors Buy Rockwell Medical (RMTI) Stock?
27-03-2026
yahoo.com
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
09-04-2026
yahoo.com
How The Rockwell Medical (RMTI) Story Is Shifting With Recalibrated Fair Value Targets
28-04-2026
yahoo.com
Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability
07-05-2026
yahoo.com
Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates
07-05-2026
yahoo.com
Rockwell Medical, Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
RMTI Q1 2026 Earnings Transcript
08-05-2026
fool.com
Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis
14-05-2026
yahoo.com
Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis
20-05-2026
yahoo.com
What is the current price of ROCKWELL MEDICAL INC (RMTI:NASDAQ)?
The current price of ROCKWELL MEDICAL INC (RMTI:NASDAQ) is $0.6757.
ROCKWELL MEDICAL INC (RMTI:NASDAQ) absolute price change since previous trading day?
The absolute price change of ROCKWELL MEDICAL INC (RMTI:NASDAQ) since the previous trading day is $-0.0334.
ROCKWELL MEDICAL INC (RMTI:NASDAQ) percentage price change since previous trading day?
The percentage price change of ROCKWELL MEDICAL INC (RMTI:NASDAQ) since the previous trading day is -4.7102%.
What is the most recent average sentiment score for ROCKWELL MEDICAL INC (RMTI:NASDAQ)?
The most recent average sentiment score for ROCKWELL MEDICAL INC (RMTI:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ROCKWELL MEDICAL INC (RMTI:NASDAQ)?
The most recent sentiment for ROCKWELL MEDICAL INC (RMTI:NASDAQ) is .
SEC-8K** Filing Available For ROCKWELL MEDICAL INC (RMTI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.